Analyst Ratings January 26, 2026

BofA Starts Coverage on Lazard with Buy Rating, Cites Diversified Revenue Mix

Bank sets $65 target as asset management and a proposed turnaround plan support bullish view

By Sofia Navarro LAZ
BofA Starts Coverage on Lazard with Buy Rating, Cites Diversified Revenue Mix
LAZ

BofA Securities began coverage of Lazard (LAZ) with a Buy rating and a $65 price objective, noting the company's significant asset management contribution to revenue, cyclical M&A tailwinds, and progress on a multi-year turnaround. The firm highlighted Lazard's dividend history, recent AUM growth, and management appointments while UBS initiated coverage with a Neutral view and a $54 target.

Key Points

  • BofA initiated coverage on Lazard with a Buy rating and a $65 price target, implying about 27% upside from a $51.37 share price.
  • Lazard's asset management business contributes roughly 40% of revenues; AUM rose to $254.3 billion as of December 31, 2025, driven by market and foreign exchange appreciation.
  • UBS began coverage with a Neutral rating and $54 target; analyst notes expect productivity gains in Financial Advisory but say consensus already reflects those improvements.

BofA Securities has commenced coverage of Lazard (NYSE:LAZ) with a Buy rating and established a $65.00 price target, representing roughly a 27% upside relative to the stock's then-current quote of $51.37.

The initiation draws attention to Lazard's more diversified business mix versus many of its advisory peers, with BofA noting that global asset management accounts for about 40% of the firm's total revenues. The investment bank also identified cyclical support for merger-and-acquisition activity as a constructive force for both Lazard's financial advisory and asset management operations.

On capitalization and shareholder returns, BofA's note references a market capitalization of $4.87 billion and points out that Lazard has paid dividends for 21 consecutive years, yielding 3.89% as reported in InvestingPro data.


Assets under management and recent appointments

Lazard reported assets under management of approximately $254.3 billion as of December 31, 2025, up from $250.8 billion in November. The firm attributed the increase to $2.2 billion of market appreciation and $1.5 billion of foreign exchange gains, partially offset by net outflows of $0.3 billion. In a personnel move tied to its investment platform, Lazard Asset Management appointed Eric Van Nostrand as its first Chief Investment Officer.

Separately, the company added three managing directors to its Global Industrials Group, a step described as intended to strengthen advisory capabilities across sectors including diversified industrials and aerospace and defense.


Strategic initiatives and analyst positioning

BofA's research also referenced the "Lazard 2030" turnaround initiative launched under CEO Peter Orszag in 2023, suggesting the program may be nearing an inflection point. The bank expressed optimism that Lazard's shares could outperform peers, noting the stock has underperformed relative to competitors over one-, three- and five-year horizons.

In other analyst activity, UBS initiated coverage on Lazard with a Neutral rating and a $54 price target. UBS analyst Michael Brown indicated he expects managing director productivity in Lazard's Financial Advisory segment to rise, while observing that consensus estimates already incorporate this anticipated improvement.


Outlook

BofA's Buy initiation rests on Lazard's revenue diversification through asset management, cyclical improvements in M&A markets, and the potential progress of the company's turnaround agenda. At the same time, UBS's Neutral stance and the note that productivity gains are reflected in consensus illustrate differing analyst perspectives on near-term upside potential.

Risks

  • Net outflows from asset management - AUM growth was partially offset by $0.3 billion of net outflows, which could pressure fee revenue and affect the asset management segment.
  • Execution risk on the Lazard 2030 turnaround - The initiative may be approaching an inflection point, but its ultimate success and timing remain uncertain.
  • Market-dependence of M&A activity - BofA's positive view partly relies on cyclical tailwinds to M&A, which are sensitive to broader market and economic conditions.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026